Skip to Content

TL 383 TL 383 (Terazosin Hydrochloride 1 mg)

Pill with imprint TL 383 TL 383 is Gray, Capsule-shape and has been identified as Terazosin Hydrochloride 1 mg. It is supplied by Cadista.

Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 1 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TL 383 TL 383

Terazosin hydrochloride 1 mg TL 383 TL 383
Terazosin hydrochloride 1 mg TL 383 TL 383
Terazosin hydrochloride 1 mg TL 383 TL 383
Terazosin hydrochloride 1 mg TL 383 TL 383

Terazosin Hydrochloride

Imprint
TL 383 TL 383
Strength
1 mg
Color
Gray
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antiadrenergic agents, peripherally acting
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cadista
Inactive Ingredients
ferrosoferric oxide, gelatin, lactose monohydrate, magnesium stearate, sodium lauryl sulfate, titanium dioxide, corn starch, silicon dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
59746-0383 Jubilant Cadista Pharmaceuticals Inc.
67544-0581 Prepak Systems Inc. (repackager)

Get help with Imprint Code FAQs.

Related Images for "TL 383 TL 383"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.